{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:38:27Z","timestamp":1769128707921,"version":"3.49.0"},"reference-count":10,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>A 57-year-old man with lumbar pain and fever was diagnosed with spondylodiscitis. Afterward, he acquired full paraplegia. Image studies showed a mass extending from D9 to the vertebral canal, plus numerous adjacent osteolytic lesions. Serum immunoelectrophoresis was normal, bone marrow had 0.5% of monoclonal plasmocytes, but D9\u2019s biopsy found a plasmacytoma. Despite bone marrow aspiration results, skeleton osteolytic lesions made multiple myeloma (MM) a more plausible diagnosis, later confirmed by the biopsy. The absence of classical MM findings, alongside a medullary compression syndrome, suggested an oligosecretory MM, which was proved by an altered FLC essay. This delayed diagnosis, with multiple diagnostic misguiding leads, also presents rare IgA and lambda chains production and normal levels of uninvolved immunoglobulins. Oligosecretory MM can lead to an inaccurate and delayed diagnosis, with devastating consequences to patient\u2019s morbidity and mortality. Therefore, FLC essay is essential in early assessment of potential MM patients.<\/jats:p>","DOI":"10.1136\/bcr-2020-240404","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T11:43:23Z","timestamp":1619091803000},"page":"e240404","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Oligosecretory multiple myeloma: a devastating presentation of a difficult diagnosis"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-2506","authenticated-orcid":false,"given":"Ricardo","family":"Roque","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Hospital and University Centre of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Machado","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital and University Centre of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duarte","family":"Flor","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital and University Centre of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Cunha","sequence":"additional","affiliation":[{"name":"Allergy and Clinical Immunology Department, Hospital and University Centre of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"2025082711484990000_14.4.e240404.1","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","article-title":"Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Moreau","year":"2017","journal-title":"Ann Oncol"},{"key":"2025082711484990000_14.4.e240404.2","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21"},{"key":"2025082711484990000_14.4.e240404.3","first-page":"930","article-title":"Non-Secretory myeloma: one, two, or more entities?","volume":"27","author":"Dimopoulos","year":"2013","journal-title":"Oncology"},{"key":"2025082711484990000_14.4.e240404.4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.5858\/2006-130-1212-NPCMEM","article-title":"Nonsecretory plasma cell myeloma--becoming even more rare with serum free light-chain assay: a brief review","volume":"130","author":"Shaw","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2025082711484990000_14.4.e240404.5","first-page":"181","article-title":"Current diagnosis and treatment of spondylodiscitis","volume":"105","author":"Sobottke","year":"2008","journal-title":"Dtsch Arztebl Int"},{"key":"2025082711484990000_14.4.e240404.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq303"},{"key":"2025082711484990000_14.4.e240404.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"2025082711484990000_14.4.e240404.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.7901"},{"key":"2025082711484990000_14.4.e240404.9","first-page":"id1090","article-title":"Annals of Hematology & Oncology The Management of Spinal Cord Compression in Multiple Myeloma","volume":"3","author":"Sen","year":"2016","journal-title":"Ann Hematol Oncol"},{"key":"2025082711484990000_14.4.e240404.10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.247"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:48:58Z","timestamp":1756320538000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,22]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-240404"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240404","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}